Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Spironolactone may help treat excessive hair growth in girls, but more research is needed.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Antiandrogen therapy may help treat hidradenitis suppurativa.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

New compounds may soon be tested to treat excessive hair growth in women.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.